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We report that feeding Drosophila throughout adulthood with
4-phenylbutyrate (PBA) can significantly increase lifespan, without
diminution of locomotor vigor, resistance to stress, or reproductive
ability. Treatment for a limited period, either early or late in adult
life, is also effective. Flies fed PBA show a global increase in histone
acetylation as well as a dramatically altered pattern of gene
expression, including induction or repression of numerous genes.
The delay in aging may result from the altered physiological state.
Aging is a common biological phenomenon shared by animalsand plants (1), but our understanding of why and how we
age remains limited. It would be of great biological interest and
practical importance if we could gain insight into the molecular
basis of aging, learn to delay the aging process, and maintain the
vigor of youth.
Recent studies show that longevity can be altered by genetic
manipulations in various organisms. The mutations age-1 (2),
daf-2 (3, 4), and clk-1 (5) in Caenorhabditis elegans increase
longevity of the worm. In yeast, Sir genes extend the budding
lifespan of the mother cell (6). Drosophila lifespan is increased
by mutations in a G protein-coupled receptor in methuselah (7),
a sodium dicarboxylate cotransporter in Indy (8), an insulin
receptor substrate in chico (9), or an insulin-like receptor in InR
(10). Studies with Drosophila by transgenic methods recently
have been reviewed (11). It is obviously of great interest to
discover drugs that can extend lifespan by simple feeding.
Mimetics of superoxide dismutase and catalase have been shown
to extend lifespan in C. elegans (12). While studying the mech-
anism of drug action on neurodegenerative mutants (13), we
discovered that sodium 4-phenylbutyrate (PBA) can increase
both the median and maximum lifespan of Drosophila.
PBA is known to inhibit the activity of histone deacetylase,
thus inducing hyperacetylation of histones, hence tending to
release histones from their binding to chromatin, with conse-
quent effects on gene transcription (14). Originally approved by
the FDA as a drug to treat urea cycle disorder (15), PBA has also
been tested in treatment of several diseases. In sickle cell anemia,
PBA stimulates transcription of the normal fetal hemoglobulin
gene, which is ordinarily silent in the adult, thus substituting for
the mutated adult form (16–18). In adrenoleukodystrophy, PBA
increases production of ALDRP, a protein that can replace the
mutated ABC transporter, thus preventing the accumulation of
very long chain fatty acids (19). In cystic fibrosis, PBA prevents
degradation of the mutated cystic fibrosis transmembrane con-
ductance regulator (F508-CFTR) (20). PBA is considered to
favor differentiation of tumors, as observed in acute promyelo-
cytic leukemia (21) and prostate cancer cells (22), and is
therefore being used in various clinical cancer trials. In Fragile
X syndrome, due to expanded CGG sequences in the FMR1
gene, production of the FMR1 protein can be restored by DNA
demethylation with 5-azadeoxycytidine, combined with hyper-
acetylation of histones by PBA (23). Beneficial effects on
polyglutamine toxicity have also been reported (24). Recent
genome-wide studies in yeast of trichostatin-A sensitive histone
deacetylase function indicated its effects on transcription of
various genes (25). The relation of histone deacetylation to gene
silencing and associated changes in budding lifespan has been
documented in yeast (26, 27).
We present below the finding of extension of lifespan in
Drosophila by feeding PBA, along with data on changes in
histone acetylation and the spectrum of genes induced and
suppressed by PBA.
Materials and Methods
Fly Strains and Phenylbutyrate. The Drosophila strains w1118 and
wild-type Canton-S were used. PBA acid, sodium salt, was a
generous gift from Joseph Cooper of Medicis, Scottsdale, AZ.
The purity of the chemical was reported to be 99.6%.
Lifespan Determination. Newly eclosed flies were collected and
raised in standard corn meal agar medium (28). For each
experiment, 10 vials, each containing 20 flies, were maintained
at either 29°C or 25°C and were transferred to fresh vials every
3 days. The number of dead flies was counted every day.
Membrane Hybridization. The smart PCR cDNA synthesis kit
(CLONTECH) was used to synthesize probes for hybridization.
Total RNA was prepared from flies fed for 10 days at 29°C with
medium containing 10 mM PBA, or with plain medium. After
first strand synthesis of cDNAs by Maloney murine leukemia
virus (MMLV)-reverse transcriptase, the cDNA was amplified
by PCR, the reaction consisting of 95°C for 1 min, followed by
24 cycles of 15 seconds at 95°C, 30 seconds at 65°C, and 6 min
at 68°C. Probes were prepared by a random primed DNA
labeling method with [-32P]dCTP. Filters containing 7,500
Drosophila unique EST clones (Research Genetics, Huntsville,
AL) were prehybridized for 4 h, then probes were added to
hybridize for 16 h at 58°C in a buffer containing 1 M NaCl, 0.05
M Tris (pH 8.0), 5 mM EDTA, 1% SDS, and 10% dextran
sulfate. After hybridization, filters were washed several times
and exposed to x-ray film to identify genes that were induced or
repressed by PBA.
Reverse-Northern Blots. To quantitate changes in abundance of
individual transcripts, 500 base pairs of each candidate gene
was synthesized by PCR, and 100 ng was mounted on a nylon
transfer membrane (hybond-N, Amersham Pharmacia). Newly
emerged adult f lies were fed standard fly food containing 10 mM
PBA, or plain food, for 10 days at 29°C. Messenger RNA was
extracted and used to synthesize cDNA by MMLV-reverse
transcriptase, and probes were prepared by a random priming
and [-32P]dCTP. The nylon membrane containing candidate
genes was hybridized with the probe prepared from control f lies,
and exposed to a PhosphorImager screen (Molecular Dynamics).
After the exposure, the probe was stripped off in 10 mM
EDTA0.1% SDS at 80°C, and exposed to a PhosphorImager
screen for 18 h, to confirm that no residual probe remained. The
membrane was then hybridized again with the second probe,
prepared from PBA-fed flies. The expression level of each gene
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was quantified by using the IMAGE QUANT program (Molecular
Dynamics).
Western Blotting of Histones. Batches of 100 flies were used to
prepare histones (29). Homogenates of whole flies were centri-
fuged at 2,500  g for 10 min in a medium containing 0.05 M
glycine, 10 mM Tris potassium maleate, 5 mM MgCl2, and 10
mM mercaptoethanol (pH 7.3) to get rid of cell debris. HCl was
added to the supernatant to a final concentration of 0.25 M,
which was kept on ice for 1 h. Acid-soluble proteins were
recovered by centrifugation at 13,000 rpm for 10 min at 4°C, then
trichloroacetic acid (TCA) was added to precipitate proteins.
Ten-microgram samples of proteins were loaded on a 16.5%
polyacrylamide gel for electrophoresis, then transferred to a
poly(vinylidene difluoride) (PVDF) membrane, followed by
hybridization with antibodies to acetylated and nonacetylated
H3 and H4 (Upstate Biotechnology, Lake Placid, NY). To verify
that any residual PBA in fly bodies would not affect acetylation
of histones during their purification, we added 30 mM PBA to
the homogenate buffer before isolation of nuclei and histones,
and found no difference.
Results and Discussion
To test the action of PBA in vivo, we fed newly eclosed flies of
the w1118 strain, throughout their lifetime, with standard fly
medium (cornmeal, agar, dextrose, yeast; ref. 28) containing
various concentrations of the drug (0, 0.1, 1, 2.5, 5, 10, 20, and
40 mM). Lifespan was measured both at 29°C and 25°C. Ten
millimolar PBA showed a striking extension of both median and
maximum lifespan (Fig. 1 a and c). At the higher concentrations,
20 mM and 40 mM, PBA was apparently toxic, reducing survival;
there is a narrow range of PBA concentration that is effective for
lifespan extension. To determine whether the drug is also
effective on a different Drosophila strain, we also measured the
effect of PBA on lifespan of the wild-type strain Canton-S (C-S),
using 0, 2, 5, and 10 mM PBA. Five millimolar increased lifespan
as much as did 10 mM with the w1118 strain (Fig. 1b), whereas 2
mM had no effect and 10 mM was toxic. Thus, the optimal PBA
concentration appears to vary with genetic background. As
shown below, the degree of inhibition of histone deacetylase also
differed in the same way between these two strains.
It has been suggested that early events in life can delay the
onset of aging, thus extending longevity (1). We were therefore
curious to know whether a limited period of PBA treatment,
early or late, can extend longevity. Newly emerged adult w1118
f lies were fed with PBA, at the optimal concentration of 10 mM,
from emergence to 12 days (before survival begins any rapid
decline), then transferred to plain medium for the rest of their
lifetime. Alternatively, f lies were fed plain medium for their first
12 days, then medium containing the drug for the remainder of
life. In both cases, the PBA-treated flies showed increased
lifespan compared with untreated flies (Fig. 2 a and b). In
females, treatment initiated at a later age was even more
effective than the same duration of treatment at young age. The
results suggest that establishment of an altered cellular environ-
ment by PBA, albeit for a limited period, can extend the lifespan
of flies, possibly by inhibiting the accumulation of damage,
andor stimulating repair mechanisms.
To test the issue of possible caloric restriction effects, we
compared the flies for weight and size after 10 days of feeding
at 25°C, with or without PBA, and no difference was observed.
We measured the number of eggs produced, the percentage of
eggs yielding adult progeny, and the weight and size of the
progeny. In all those measurements, there was no detriment due
to feeding PBA (Table 1). Qualitative observations on ingestion
of food dye were consistent with that conclusion.
We tested other parameters to determine whether, associated
with the extension in lifespan, there was also extended mainte-
nance of vigor. Locomotor ability, as measured by climbing in
the negative geotactic response (Fig. 3a), resistance to starvation
(Fig. 3b), and resistance to the free radical generator paraquat
(Fig. 3c) all showed extension of healthy lifespan, as compared
with controls not fed PBA.
Because PBA, an inhibitor of histone deacetylase, is known to
enhance acetylation of the tails of histones H3 and H4, we
investigated the level of histone acetylation in flies with and
without PBA feeding, using specific antibodies on Western blots.
As shown in Fig. 4 a and b, the nonacetylated forms of these
histones were predominant in untreated flies, but PBA feeding
increased the proportions of their acetylated forms. Similar
Fig. 1. Lifespan extension by feeding PBA. Newly emerged adult flies were
fed continuously on standard cornmealyeastagar medium, with or without
added PBA, and survival curves were measured. Each initial population was
400 flies. Data were combined from two separately run groups of 100 males
plus two separately run groups of 100 virgin females. (a) w1118 strain at 29°C.
Ten millimolar PBA extends median survival by 33% (mean survival by 36%,
maximum survival by 52%). (b) Canton-S wild type strain at 29°C. Five milli-
molar PBA extends median survival by 36% (mean survival by 40%, maximum
by 41%). (c) w1118 strain at 25°C. PBA is also effective at the lower temperature.
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results were obtained for both males and females (Fig. 4c). These
changes in histone acetylation suggested possible modifications
of chromatin structure, which might change the regulation of
transcription.
To investigate the differential patterns of gene activity result-
ing from PBA treatment, high density membrane arrays con-
taining an estimated 7,500 unique Drosophila EST clones (Re-
search Genetics, Huntsville, AL) were used. Messenger RNA
was prepared from flies maintained at 29°C on food containing
10 mM PBA from emergence to 10 days of age, and a similar
preparation was made from untreated flies. These were labeled
with 32P and used as probes on the membranes.
Fig. 5a shows a sample portion of the array hybridized with
each of the two different probes, to illustrate the choosing of 100
genes that were induced by PBA, based on increased intensity of
hybridization. Conversely, we chose 48 genes that were sup-
pressed by the treatment, as judged by disappearance of a visible
spot. The patterns were reproducible with two indepen-
dent preparations of mRNA each from treated and untreated
flies, and with two independent pairs of membranes for each
preparation.
The 100 induced genes included 3 that previously have been
implicated in detoxification, 3 chaperones, 2 involved in trans-
lation machinery, 3 transcription factors, 7 involved in signal
transduction pathways, 25 involved in metabolism, 11 ribosomal
Fig. 2. PBA extends lifespan whether fed early or late in life. Newly emerged
w1118 flies were fed on medium plus 10 mM PBA for 12 days, then transferred
to normal medium for the rest of their lifespan. Converse group was fed on
normal medium for the first 12 days, then with PBA for the remainder of life.
Arrows indicate day 12. Each initial population was 200 flies. (a) Virgin
females; (b) males.
Table 1. Comparison of weight, size, and reproductive ability of
w1118 flies after being maintained on food with or without 10
mM PBA for 10 days at 25°C
Control PBA
Parent
Weight of 5 flies, mg (n  10)
Females 5.1  0.2 5.1  0.2
Males 3.3  0.1 3.3  0.4
Size of a fly, mm (n  40)
Female 5.5  0.1 5.5  0.1
Male 4.5  0.1 4.6  0.1
Egg laying (3 males  3 females a vial
for 16 h; n  20 vials)
66  16 67  15
% of eggs yielding adults (n  20 vials) 66  15 70  16
Progeny
Weight of 5 flies, mg (n  10)
Females 5.3  0.4 5.2  0.2
Males 3.4  0.6 3.5  0.3
Size of a fly, mm (n  40)
Female 5.4  0.2 5.5  0.1
Male 4.5  0.2 4.6  0.2
Flies were weighed in batches of five. Size is the length of the fly from front
of head to tip of abdomen as measured with an eyepiece micrometer. Eggs
laid were counted after 16 h with three males and three females per vial.
Values represent mean  SD. None of these parameters showed any signifi-
cant differences due to feeding PBA.
Fig. 3. PBA inspires maintenance of locomotor ability and resistance to
stress. For each experiment, n  80 w1118 flies, repeated four times. (Left)
Virgin females; (Right) males. In all these paradigms, both male and female
PBA-treated flies showed superior performance. (a) Locomotor ability assayed
by climbing test for three transfers in a ‘‘counter current distribution’’ appa-
ratus (41) held vertically. Flies that climbed to the upper tube three times out
of three trials were counted as positive. Flies were maintained at 29°C for 10
days with or without PBA before testing. (b) Resistance to dry starvation. Flies
raised for 10 days at 25°C with or without 10 mM PBA were put into empty vials
to test their survival measured vs. time. (c) Resistance to paraquat, a free-
radical generator. Flies raised for 10 days at 25°C with or without 10 mM PBA
were first deprived of water in an empty vial for 3 h, then transferred to a vial
containing filter paper wetted with 350 l of 20 mM paraquat in 5% sucrose.
Values represent mean  SD for the four runs. Student’s t test was used to
analyze the significant difference between controls and PBA-treated flies.
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proteins, 11 proteases, 4 kinases, 13 genes that function as
transporters or carriers, and 18 others involved in other miscel-
laneous functions. Among the 48 repressed genes, there were 21
involved in metabolism, 4 proteases, 2 ribosomal proteins, and 21
others having other miscellaneous functions.
To verify the changes in transcription levels indicated on the
microarrays, we used reverse-Northern blots on a subset of the
candidate genes. Seven of the induced genes were chosen
because of their putative involvement in enhancing longevity:
superoxide dismutase, elongation factor1, glutathione S-
transferase, cytochrome P450, and three chaperones. In Dro-
sophila, transgenic flies with superoxide dismutase genes have
been reported to show extended mean lifespan (30–32). Elon-
gation factor 1 plays a critical role in maintaining the level of
protein synthesis, which normally declines with age (33). Glu-
tathione S-transferase and cytochrome P450 are involved in
detoxification, one of the determinants of aging (1, 34). Heat
shock proteins enhance resistance to stress and extend lifespan
(35, 36). All of these genes were induced by PBA, as confirmed
in Fig. 5b. Note that superoxide dismutase (SOD) expression, in
particular, was dramatically increased.
Nineteen additional genes were chosen at random, 6 of the
induced group and 13 of the repressed group. All were con-
firmed by reverse-Northern blot, supporting the membrane
screening method used in identifying the genes. The genes are
listed in Table 2, grouped according to their putative functions.
Whether the observed changes in gene transcription, or a
subset of them, are responsible for the increased longevity will
require testing each candidate gene individually by overexpres-
Fig. 4. Effect of feeding PBA on acetylation of histones H3 and H4. w1118 flies
were raised for 10 days at 29°C on medium containing various concentrations
of PBA. Histones prepared from whole flies were probed on Western blots
with antibodies specific for acetylated or nonacetylated forms of the tails of
histones H3 and H4. Ten micrograms of histone were used per lane. In flies
treated with PBA, the acetylated forms of both H3 and H4 were increased,
whereas the nonacetylated forms decreased. (a) Histone H3 in w1118 flies.
Abundance of the acetylated form increases with concentration of PBA added
to the food. The nonacetylated form decreases (mixed males and virgin
females). (b) Similar result for histone H4 in w1118 flies (mixed males and virgin
females). (c) w1118 males and virgin females assayed separately. The effect of
PBA is similar in both sexes. (d) Increase of acetylation of histone H3 in
wild-type strain Canton-S (mixed males and virgin females).
Fig. 5. Induction or repression of transcription of various genes by PBA,
verified by reverse-Northern blots. (a) Sample area of membrane microarray
of cDNA clones hybridized with mRNA probes prepared from w1118 flies raised
with or without 10 mM PBA for 10 days at 29°C. The area shown contained 180
clones of the array. Arrows at right illustrate typical spots selected as candi-
dates for increased abundance of mRNA in PBA-treated flies. (b) Reverse-
Northern blots for genes induced by PBA: 1, heat shock protein cognate 70–4;
2, daughterless; 3, elongation factor 1 48D; 4, heat shock protein 60; 5,
mitochondrial phosphate carrier protein; 6, inebriated; 7, dnaJ-like protein2;
8, imaginal disc growth factor1; 9, cytochrome P450–4d1; 10, transportin; 11,
superoxide dismutase; 12, epididymal secretory protein; 13, glutathione S-
transferase; 14, Control  nina E, which showed similar expression with or
without PBA treatment. (c) Genes repressed by PBA: 21, glyceraldehyde-3-
phosphate dehydrogenase1; 22, porin; 23, NADH: ubiquinone reductase 75-
kDa subunit precursor; 24, cytochrome c oxidase; 25, osa; 26, hexokinase; 27,
dnaJ-like protein 1; 28, cytochrome c oxidase subunit VIb; 29, peptidylglycine-
-hydroxylating monooxygenase; 30, peroxysomal farnesylated protein; 31,
fatty acid synthetase; 32, calreticulin; 33, cyclin-dependent kinase 9; 34, nina
E control.
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sion in transgenic flies, or by specific inhibition. Also, which are
primary and which are downstream effects of PBA remains to be
determined. It will be a challenge to define constellations of
genes and their networks that can be responsible for increasing
lifespan.
There have been various reports of global molecular changes
associated with aging, by comparing tissues from young and old
animals (37–39), but it is difficult to determine which events are
directly involved in the aging process. The extension of lifespan of
Drosophila by treatment with PBA may serve as a useful model. In
Drosophila, transgenic constructs can readily be made to test for the
effects of overexpression or silencing of individual genes. This
system may also be useful in understanding basic mechanisms in
histone acetylation and transcriptional regulation of gene expres-
sion, by identifying common features of control regions for the
different gene responses. We observed both induction and repres-
sion of transcription by PBA. It is interesting to note that overex-
pression of Sir2 protein in both yeast (26) and C. elegans (40), which
has NAD-dependent histone deacetylase activity, is implicated in
silencing of gene transcription, associated with extension of the
lifespan, whereas deletion of a different histone deacetylase
(RPD3) also extends lifespan (27). This conundrum suggests that
the underlying mechanism for the extension of lifespan may be an
optimal balance of expression and repression of various genes to
regulate an optimal physiological and cellular environment for
longevity. That finding would be consistent with our observation on
the concentration dependence of PBA fed to flies, which shows
counterproductive effects at excess levels as is typical of drug-
dosage effects. The genes induced or suppressed by PBA therefore
warrant equal attention in further study.
It is intriguing that PBA treatment late in the life of the adult
f ly can still be effective. Whatever the mechanisms, our obser-
vation that simple feeding of a drug can enhance lifespan, along
with improved maintenance of vigor, strongly suggests the
feasibility of high throughput screening, for which Drosophila
represents a convenient model organism. It will also be of
interest to determine whether PBA treatment of other animals
can affect their lifespan.
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